Broadwood Partners Lp, Director, Ten Percent Owner at Lineage Therap, holds 12.49M shares in OncoCyte (Ticker: OCX), holds 21.56M shares in Staar Surgical (Ticker: STAA), holds 83.42M shares in Lineage Therap (Ticker: LCTX). Most recently, Broadwood Partners Lp Bought ― shares of OncoCyte on Oct 04, 2024 for an estimated value of 3.87M.
What was Broadwood Partners Lp’s latest transaction?
Broadwood Partners Lp latest transaction was an Informative Buy of $3.87M.
What was Broadwood Partners Lp's most profitable transaction?
Broadwood Partners Lp’s most profitable transaction was an Informative Buy of OCX stock on April 28, 2020. The return on the trade was 123.60%.
What is Broadwood Partners Lp's role in Lineage Therap?
Broadwood Partners Lp's role in Lineage Therap is Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.